Dopamine receptor interacting proteins (DRIPs) of dopamine D1-like receptors in the central nervous system

被引:0
|
作者
Wang, Min [1 ]
Lee, Frank J. S. [1 ]
Liu, Fang [1 ,2 ]
机构
[1] Ctr Addict & Mental Hlth, Dept Neurosci, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5T 1R8, Canada
关键词
dopamine; dopamine D1-like receptors; dopamine receptor-interacting proteins (DRIPs); neuropsychiatric; disease;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dopamine is a major neurotransmitter in the mammalian central nervous system (CNS) that regulates neuroendocrine functions, locomotor activity, cognition and emotion. The dopamine system has been extensively studied because dysfunction of this system is linked to various pathological conditions including Parkinson's disease, schizophrenia, Tourette's syndrome, and drug addiction. Accordingly, intense efforts to delineate the full complement of signaling pathways mediated by individual receptor subtypes have been pursued. Dopamine D1-like receptors are of particular interest because they are the most abundant dopamine receptors in CNS. Recent work suggests that dopamine signaling could be regulated via dopamine receptor interacting proteins (DRIPs). Unraveling these DRIPs involved in the dopamine system may provide a better understanding of the mechanisms underlying CNS disorders related to dopamine system dysfunction and may help identify novel therapeutic targets.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 50 条
  • [1] Voltage-Dependent Dopamine Potency at D1-Like Dopamine Receptors
    Agren, Richard
    Sahlholm, Kristoffer
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [2] Dopamine D1-like receptors regulate the α1A-adrenergic receptor in human renal proximal tubule cells and D1-like dopamine receptor knockout mice
    Ennis, Riley Charles
    Asico, Laureano D.
    Armando, Ines
    Yang, Jian
    Feranil, Jun B.
    Jurgens, Julie A.
    Escano, Crisanto S., Jr.
    Yu, Peiying
    Wang, Xiaoyan
    Sibley, David R.
    Jose, Pedro A.
    Villar, Van Anthony M.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 307 (11) : F1238 - F1248
  • [3] Dopamine depolarizes podocytes via a D1-like receptor
    Bek, M
    Fischer, KG
    Greiber, S
    Hupfer, C
    Mundel, P
    Pavenstädt, H
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) : 581 - 587
  • [4] MOLECULAR DIVERSITY OF DOPAMINE D1-LIKE RECEPTORS IN THE EUROPEAN EEL
    CARDINAUD, B
    QUERAT, B
    DUFOUR, S
    VINCENT, JD
    VERNIER, P
    NETHERLANDS JOURNAL OF ZOOLOGY, 1995, 45 (1-2): : 235 - 237
  • [5] The Dopamine D1-like Receptors Negatively Regulate the Expression and Function of the a1A Adrenergic Receptor
    Ennis, Riley C.
    Villar, Van Anthony M.
    Asico, Laureano D.
    Escano, Crisanto S.
    Feranil, Jun B.
    Jurgens, Julie A.
    Jones, John E.
    Jose, Pedro A.
    HYPERTENSION, 2013, 62 (03)
  • [6] Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose
    D'Aquila, Paolo S.
    NEUROPHARMACOLOGY, 2010, 58 (07) : 1085 - 1096
  • [7] SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism
    Adachi, K
    Ikeda, H
    Hasegawa, M
    Nakamura, S
    Waddington, JL
    Koshikawa, N
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 367 (2-3) : 143 - 149
  • [8] A PET study of D1-like dopamine receptor ligand binding
    Y.-H. Chou
    P. Karlsson
    Christer Halldin
    Hans Olsson
    Lars Farde
    Psychopharmacology, 1999, 146 (2) : 220 - 227
  • [9] Pharmacology of signaling induced by dopamine D1-like receptor activation
    Undieh, Ashiwel S.
    PHARMACOLOGY & THERAPEUTICS, 2010, 128 (01) : 37 - 60
  • [10] Three distinct dopamine D1-like receptor signaling pathways
    Kuroiwa, Mahorni
    Bateup, Helen S.
    Shuto, Takahide
    Nishi, Akinori
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 279P - 279P